Selective inhibition of human type 1 11β-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics

被引:56
作者
Hult, M [1 ]
Jörnvall, H [1 ]
Oppermann, UCT [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
关键词
11 beta-hydroxysteroid dehydrogenase; glucocorticoid; short-chain dehydrogenase/reductase; yeast expression; membrane protein;
D O I
10.1016/S0014-5793(98)01515-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Functional analyses were performed with microsomal human 11 beta-hydroxysteroid dehydrogenase type 1 overexpressed in the yeast Pichia pastor is. Cell extracts or microsomes from transformed strains displayed dehydrogenase and reductase activities, which were up to 10 times higher than in human liver microsomes, while for whole cells cortisone reduction but no dehydrogenase activity was observed. The synthetic glucocorticoids prednisolone and prednisone were efficiently metabolized by subcellular fractions, whereas no activity was observed with dexamethasone, budesonide and deflazacort. Inhibitors found to be effective towards the recombinant 11 beta-hydroxysteroid dehydrogenase include synthetic steroids and xenobiotic compounds, revealing selective inhibition of the reaction direction, useful for development of specific inhibitors. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 24 条
[1]   MUTATIONS IN PUTATIVE GLYCOSYLATION SITES OF RAT 11-BETA-HYDROXYSTEROID DEHYDROGENASE AFFECT ENZYMATIC-ACTIVITY [J].
AGARWAL, AK ;
MUNE, T ;
MONDER, C ;
WHITE, PC .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1995, 1248 (01) :70-74
[2]   EXPRESSION OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE USING RECOMBINANT VACCINIA VIRUS [J].
AGARWAL, AK ;
TUSIELUNA, MT ;
MONDER, C ;
WHITE, PC .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1827-1832
[3]   STEROID-HORMONE RECEPTORS - MANY ACTORS IN SEARCH OF A PLOT [J].
BEATO, M ;
HERRLICH, P ;
SCHUTZ, G .
CELL, 1995, 83 (06) :851-857
[4]   Dexamethasone and 11-dehydrodexamethasone as tools to investigate the isozymes of 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo [J].
Best, R ;
Nelson, SM ;
Walker, BR .
JOURNAL OF ENDOCRINOLOGY, 1997, 153 (01) :41-48
[5]   Does central obesity reflect ''Cushing's disease of the omentum''? [J].
Bujalska, IJ ;
Kumar, S ;
Stewart, PM .
LANCET, 1997, 349 (9060) :1210-1213
[6]   RECENT ADVANCES IN THE EXPRESSION OF FOREIGN GENES IN PICHIA-PASTORIS [J].
CREGG, JM ;
VEDVICK, TS ;
RASCHKE, WC .
BIO-TECHNOLOGY, 1993, 11 (08) :905-910
[7]   PHARMACOLOGY OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE [J].
FREY, FJ ;
ESCHER, G ;
FREY, BM .
STEROIDS, 1994, 59 (02) :74-79
[8]   11 beta-hydroxysteroid dehydrogenases of the choriocarcinoma cell line JEG-3 and their inhibition by glycyrrhetinic acid and other natural substances [J].
GomezSanchez, EP ;
Cox, D ;
Foecking, M ;
Ganjam, V ;
GomezSanchez, CE .
STEROIDS, 1996, 61 (03) :110-115
[9]   SHORT-CHAIN DEHYDROGENASES REDUCTASES (SDR) [J].
JORNVALL, H ;
PERSSON, B ;
KROOK, M ;
ATRIAN, S ;
GONZALEZDUARTE, R ;
JEFFERY, J ;
GHOSH, D .
BIOCHEMISTRY, 1995, 34 (18) :6003-6013
[10]   DIETARY ESTROGENIC ISOFLAVONES ARE POTENT INHIBITORS OF BETA-HYDROXYSTEROID DEHYDROGENASE OF P-TESTOSTERONII [J].
KEUNG, WM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 215 (03) :1137-1144